In terms of screening for obstructive sleep apnea in people living with HIV, the STOP-BANG questionnaire had good sensitivity, whereas the Berlin questionnaire and the Epworth Sleepiness Scale demonstrated good specificity.
The Infectious Disease Society of America has issued guidelines to aid in the treatment and management of patients with COVID-19.
The effects of the COVID-19 pandemic have caused more significant change than previously expected as the United States now has the most cases worldwide.
New evidence supports the possibility of gastrointestinal infection with the novel SARS-CoV-2 virus, as well as a possible feco-oral route of transmission.
As infections with SARS-CoV-2 continue to increase, there has been a concurrent increase in news and data, both accurate and inaccurate.
The first case of COVID-19 as a result of infection with SARS-CoV-2 was confirmed in New York City; the first death related to the infection has also been reported.
The Centers for Disease Control and Prevention has issued an official health update for the outbreak of novel coronavirus 2019-nCoV.
Although uptake was limited, prophylactic treatment with moxifloxacin was well-tolerated in individuals with evidence of latent tuberculosis who were in contact with patients with high-risk multidrug-resistant tuberculosis.
Delafloxacin may provide a feasible alternative antibiotic monotherapy option for treating patients with community-acquired bacterial pneumonia (CABP) who have renal impairment in both inpatient and outpatient settings.
Lefamulin appears to be noninferior in safety and efficacy compared with moxifloxicin in the treatment of community-acquired bacterial pneumonia.
